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ABSTRACT 
 
Background: Prosthetic vascular graft infection (PVGI) is a severe complication associated with high 
morbidity and mortality. Clinical diagnosis is complex, requiring image testing such as CT angiography 
or leukocyte scintigraphy, which have considerable limitations. The aim of this study was to know the 
diagnostic yield of PET/CT with 
18
F-Fluorodeoxyglucose (
18
F-FDG) in patients with suspected PVGI. 
Methods: We performed a prospective cohort study including 49 patients with suspected PVGI, median 
age of 62±14 years. Three uptake patterns were defined following published recommendations: (i) focal 
or (ii) patched (PVGI criteria) and (iii) diffuse (no PVGI criterion). Results: Sensitivity, specificity, and 
positive and negative predictive values for 
18
F-FDG PET/CT were 88%, 79%, 67% and 93%, 
respectively. 
18
F-FDG PET/CT identified 14/16 cases of PVGI showing a focal (n=10) or patched pattern 
(n=4), being true negative in 26/33 cases with either a diffuse pattern (n=16) or without uptake (n=10). 
Five of the seven false positive cases (71%) showed a patched pattern and all coincided with the 
application of adhesives for PVG placement. Conclusions: 
18
F-FDG PET/CT is a useful technique for the 
diagnosis of PVGI. A patched pattern on PET/CT in patients in whom adhesives were applied for 
prosthetic vascular graft placement does not indicate infection. 
 
Keywords: Fluorodeoxyglucose (FDG), Diagnostic and prognostic application, PET/CT imaging. 
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ABBREVIATIONS 
 
PVGI  Prosthetic vascular graft infection 
18
F-FDG 
18
F-Fluorodeoxyglucose 
PTFE  Polytetrafluoroethylene 
CT  Computed Tomography 
SUV  Standardized uptake value 
M-TBR  Maximum target-to-blood pool ratio  
AUC  Area under the receiver-operating characteristic curve 
GNR  Gram-negative rods 
PPV  Positive predictive value 
NPV  Negative predictive value 
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INTRODUCTION 
 
 Prosthetic vascular graft infection (PVGI) is a severe complication, albeit relatively rare 
(incidence rate between 1% and 6%), which may develop following reconstructive surgery. It requires 
immediate accurate diagnosis, and in some cases may lead to serious complications with mortality rates 
as high as 40% at five years according to the series (1-2). The risk of infection varies according to the 
location of the prosthesis: aortic grafts limited to the abdomen have a risk of around 1% whereas the 
percentage varies from 1.5% to 2% in the aortofemoral and may be of up to 6 % in the infrainguinal 
arteries (1). Synthetic grafts are made of either Dacron or polytetrafluoroethylene (PTFE) and both 
materials may be used for endovascular implants and for open surgery. Dacron grafts are more 
susceptible to infections and are mainly used in large vessels in aortic and aortoiliac surgery, whereas 
PTFE peripheral implants are preferably used for medium and small vessels (3). 
 
 The diagnosis of prosthetic infection is based on the presence of clinical manifestations, 
laboratory, microbiological and imaging results. Several studies with computed tomography (CT)(1) have 
described very good diagnostic accuracy with this method in patients with advanced graft infection, 
reporting a sensitivity and specificity of around 94% and 85%, respectively (4). However, CT usually 
fails to differentiate changes in the early period post- surgery and to detect low-grade infection, having a 
sensitivity and specificity about 55% and 100%, respectively (5). 
 
 The use of radiolabeled leukocytes has been quite successful in detecting low-grade PVGIs, but 
low resolution hinders their ability to differentiate adjacent soft tissue infections (6). Preliminary studies 
found 
18
F-FDG-PET to be more accurate compared to contrast CT but showing potential high 
18
F -FDG 
uptake in non infected vascular grafts requiring PET/CT findings to be interpreted with caution (7-8). 
Thereafter, other groups suggested the higher sensitivity and specificity of PET/CT using focal and 
diffuse patterns trying to differentiate infection from inflammatory and/or physiologic uptake (9-10). 
However, more recent studies have coincided in the need to define non homogeneous or patched uptake 
patterns (11-12) and the degree of uptake (13) necessary to establish a differential diagnosis of PVGI. 
Other relevant technical aspects to correctly interpret PET/CT findings include the progressive use of 
surgical adhesives which produce severe active inflammation surrounding the glue remnant and show 
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increased heterogeneous 
18
F-FDG uptake making it difficult to distinguish between PVGI or 
inflammatory changes (3). In this context, a study by Guenther et al showed a surprisingly low specificity 
for PET/CT in the diagnosis of infection of the proximal thoracic aorta (14). A case definition was 
recently proposed for aortic graft infections, with PET/CT being considered as a minor criterion (15). 
 
 The primary aim of this study was to evaluate the diagnostic yield of PET/CT in patients with 
suspected PVGI. The secondary aims were to determine the usefulness of PET/CT to discriminate 
between PVGI and infectious processes of adjacent tissues and the influence of bioglue in 
18
F-FDG 
uptake. 
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MATERIALS AND METHODS 
 
Patients and Design 
 We performed a prospective cohort study from 49 consecutive patients with suspected PVGI 
attended in an 850-bed university hospital from June 2014 to July 2016.Since 1979, all patients with 
PVGI attended at the Hospital Clinic of Barcelona have been managed by a multidisciplinary group 
which meets on a weekly basis. Patients were classified in line with the Samson Classification for 
vascular graft infection according to the depth of infection and degree of graft involvement (16). The 
study was approved by the Institutional Review Board and written informed consent to perform PET/CT 
was obtained from all the patients included. 
 
Diagnosis of PVGI was confirmed by clinical/surgical, radiologic and laboratory findings in the 
presence of a single major criterion (pus, exposed graft, fistula, perigraft fluid or gas on CT and 
organisms recovered from graft or perigraft fluid), plus any other criterion major or minor (localized 
clinical features, fever, radiological suspicion of a related infection, positive blood cultures and elevated 
inflammatory markers), as described in the literature by Lyons et al (15). PET/CT was not used for PVGI 
diagnosis to ensure that there was no influence on the outcomes. PVGI was ruled out by a combination of 
biochemical, clinical, and imaging parameters (other than PET/CT) and a minimum follow-up of six 
months. 
 
PET/CT 
 Whole-body scans were performed using a hybrid PET/CT (SIEMENS Biograph mCT 64S). The 
patients underwent a 6-h fast period with blood glucose levels less than 140 mg/dl prior to the intravenous 
administration of 0.11 mCi (4.07 MBq)/kg of 18F-FDG. During the acquisitions, patients were in supine 
position with their arms raised above their head. Whole-body PET data were acquired 1h after 
18
F-FDG 
administration in 3D mode and for 3 minutes per bed position. PET images were reconstructed using the 
ordered-subsets expectation maximization algorithm with and without CT data for attenuation correction. 
PET, CT, and fused PET/CT images were available for review and shown in axial, coronal, and sagittal 
planes. 
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Image Interpretation 
 Images were interpreted separately by two nuclear medicine specialists trained in infection and 
18
F-FDG PET/CT. Disagreements were settled by consensus with a third nuclear medicine specialist. Foci 
of increased 
18
F-FDG uptake were recorded. Three uptake patterns were defined visually following 
published recommendations: (i) focal (one dominant area of uptake) or (ii) inhomogeneous or patched 
(PVGI criteria) and (iii) diffuse or homogenous (no PVGI criterion) (9).
18
F-FDG uptake in the region of 
the vascular graft was evaluated with 3D and volume rendering image fusion using software based on the 
Unix system to visually establish the uptake pattern and if the 
18
F-FDG uptake corresponded to the 
vascular graft or to the adjacent tissues (Osirix, Pixmeo, Geneva, Switzerland). 
 
 Additionally, a semi-quantitative analysis was made using the maximum standardized uptake 
value (SUVmax) in a spherical volume of interest area of suspected infection. The mean standard uptake 
value (SUVmean) was obtained in the blood pool using superior cava vein uptake. A Maximum target-to-
blood pool ratio (M-TBR) was calculated by dividing the SUVmax of the area of interest by the 
SUVmean of the blood pool. 
 
Statistical Analysis 
 The statistical analyses were performed using the SPSS, version 22.0 (SPSS Inc.). The 
sensitivity and specificity and the positive (PPV) and negative predictive values (NPV) were calculated. 
Inter-rater agreement with Kappa statistics was obtained. Areas under the receiver-operating 
characteristic curve (AUC) and total and sensitivity optimization thresholds were calculated.  Differences 
in continuous and categorical variables on table 1 were measured by Kruskal-Wallis test and by χ2 test, 
respectively. A two-sided p-value<0.05 was considered significant. 
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RESULTS 
 
 Table 1 shows the baseline characteristics of the patients. The mean age ± standard deviation 
(SD) of the patients recruited (42 men and 7 women) was 62±14 years. The median time span between 
PVG placement and PET/CT was six months (interquartile range [IQR] =2-36), and 44 patients (90%) 
received antibiotics before PET/CT. A final diagnosis of PVGI was established in 16 patients: with 
infection of the ascending aorta (n= 2), aortobifemoral (n= 3), aortoiliac (n= 1), axillofemoral (n= 1), 
femoral (n=2), femoropopliteal (n= 5) and other locations (n= 2). See Table 2. All 16 patients classified 
as PVGI had at least one major and one minor criterion based on the case definition by Lyons et al (15). 
Following Samson classification, nine out the 16 patients with confirmed PVGI were in group 4 (n=5) 
orgroup 5 (n=4). Eight patients were diagnosed with infection of adjacent tissues not related to the 
PVG.The causative microorganism was identified in 15 out of 16 infections, with coagulase- negative 
Staphylococci (n= 4) and polymicrobial isolates (n= 4) being the most frequent (Table 2). 
 
 In our series, 
18
F-FDG PET/ CT was able to identify 14/16 cases of PVGI (Figure 1) showing a 
focal (n=10) or patched pattern (n=4) and was true negative in 26/33 cases with either a diffuse pattern 
(n=16) or without uptake (n=10). The remaining 7/33 non infected cases were considered as false positive 
results and showed a patched (n=6) or focal (n=1) uptake. The sensitivity, specificity, PPV and NPV for 
18
F-FDG PET/CT were 88%, 79%, 67% and 93%, respectively. Two false negative cases were found in 
the ascending aorta and in the femoral PVG. The duration of antibiotic use in these two cases was 18 and 
14 days, and the mean duration in PVGI group was 15 days (see Table 1). Five out of the 7 false positive 
cases (71%) showed a patched pattern (2 cases in the anastomotic site and 3 cases throughout the vascular 
graft), coinciding with the application of adhesives for PVG placement (Figure 2). When these cases were 
excluded from the analysis, these PET/CT values rose to up to 88%, 93%, 87% and 93%, respectively. 
Additionally, PET/CT identified all the extra-prosthetic infections not identified by other procedures in 
the area surrounding the vascular graft: abscesses (n=2), aneurysm (n=3), infected hematoma (n=2) and 
sternal osteomyelitis (n=1). These cases represented 16% of the total number of patients and PET/CT was 
determinant in establishing that the infection was not related to the PVG (Figure 3). 
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Quantitative analysis for PET/CT using AUC showed that the best thresholds to discriminate 
between infection and inflammatory and/or physiological uptake were a SUVmax = 4.2 (75%, 78.79%) 
and a M-TBR = 1.83 (93.75%, 66.67%) (Figure 4). 
 
There was an agreement between the two observers to establish 
18
F-FDG uptake pattern as 
patched, focal or diffuse in 38 of the 49 (78%) cases. When considering only two categories as infected 
(patched and focal patterns) or not infected (diffuse pattern), the agreement rose to 45 out of 49 (92%). 
The same analysis using Kappa statistics values to measure inter-rater agreement between operators were 
0.618 (confidence interval [CI] 95%; 0.420, 0.817) and 0.835 (CI 95%; 0.681, 0.990), respectively. The 
Kappa coefficient was interpreted as having substantial agreement and almost perfect agreement, 
respectively. 
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DISCUSSION 
 
In this cohort of suspected PVGI, the focal 
18
F-FDG uptake pattern on PET/CT was revealed as an 
accurate parameter for infection. However, the combination of inhomogeneous or patched pattern and the 
use of adhesives can be a source of false positive results. PVGI is associated with high mortality and 
morbidity making early accurate diagnosis essential in order to provide the most appropriate treatment. 
Diagnosis of cardiovascular infections is currently dependent on the presence of certain clinical 
symptoms and echocardiographical and CT angiography findings. CT angiography is considered the gold 
standard modality in patients with suspected PVGI. However, the characteristic signs such as local 
perigraft fluid retention and air bubbles are not always present in infected cases, and they cannot be 
interpreted as pathological in the early postoperative period (3 months) (10). Although the sensitivity of 
angio-CT is relatively high at 85-100%, it may decrease in low-grade infections (17). Other post-surgical 
complications such as infected hematomas or pseudoaneurysms in the vicinity of the vascular graft may 
also make correct diagnosis difficult.  
 
 Several studies have shown that 
18
F-FDG may be a promising radiotracer for detecting 
cardiovascular infections (18-19). However, it should be noted that chronic aseptic inflammation in 
synthetic graft material, also constitutes a potential base for 
18
F-FDG uptake, even long after surgery, 
which may potentially dificult the diagnosis of PVGI (8, 13, 20). In a previous study Wasselius et al 
described 
18
F -FDG uptake in vascular grafts of a vast majority of patients without graft infection 
indicating the possible high risk of a false-positive diagnosis (8). Saleem et al reported that 
18
F-FDG 
uptake can remain long after surgery, being especially dependent on the prosthetic material used, 
especially with Dacron (21). Accordingly to previous data, we detected diffuse
18
F-FDG uptake in up to 
69% of our cases.  
 
In a study of 33 patients with an aortic graft, Fukuchi et al. found one third to be infected, with 
false positive results as high as 36% (7). This also coincides with our series in which almost half of the 
non infected vascular grafts showed a diffuse uptake pattern (16 out of 33 cases). Keidar et al analyzed 
18
F-FDG uptake in non infected PVGs in 107 cases. They found 
18
F-FGDG uptake in 92% of patients, 
although none presented a focal pattern, supporting the concept that focal uptake is a strong indicator of 
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graft infection (11). Nonetheless, we do not agree with these authors since the sensitivity in our study was 
88% with a lower specificity of 79% for PVGI when either focal or patched uptake patterns of infection 
were present. As other authors (12, 21-22), we did not find additional value of SUVmax or M-TBR to 
establish a threshold to discriminate inflammation from infection because of the rather low specificities 
with best optimal thresholds of SUVmax= 4.2 (75%, 78.79%) and M-TBR = 1.83 (93.75%, 66.67%), 
respectively. 
 
 Spacek et al were the first to report non homogeneous FDG uptake in 18.8% of cases, and of 
these 61% were infected and 39% were not. They therefore concluded that non homogeneous FDG 
uptake hampered the accuracy of PET/CT and must be considered as a non diagnostic result (12). These 
findings are crucial as focal and patched patterns can be difficult to differentiate as occurred in our series 
when the images were analyzed by two nuclear medicine specialists. This is important considering that 
the patched pattern can manifest as an inflammatory reaction and may not be due to an infectious process, 
especially in cases in which adhesives are necessary such as in open access for aortic root grafts, and 
some cases of endovascular aortic repair can show intense heterogeneous uptake (7, 23). Taking this into 
account, positive PET/CT findings in patients with aortic root prosthesis should be interpreted with 
caution and monitoring with angio-CT is recommended (3). Our results in terms of specificity for 
18
F-
FDG PET/CT, significantly improved from 79% to 93% after excluding patients in whom adhesives had 
been applied for PVG placement from the analysis. There were only two false positive cases, one 
showing a patched and one a focal uptake pattern, which were indistinguishable from PVGI. An 
interesting case report by Ruiz-Zafra et al. concludes that false-positive 18F-FDG uptake as a result of a 
foreign body reaction can occur at any time during the follow-up period after lung cancer resection due to 
surgical adhesives (24). For all these reasons, we believe that surgical reports should detail the materials 
employed and the area(s) where they were used.  
 
 Combined PET/CT with volume render 3D images has also proved useful to discriminate 
between neighboring structures and allows the best resolution images to be obtained (25). This may be an 
interesting option to apply in the field of suspected PVGI to rule out infected pseudoaneurysms or 
hematomas close to the vascular graft. Indeed, we confirmed infection in the adjacent soft tissues of the 
suspected infected vascular graft showing a focal or heterogeneous uptake pattern in 8 cases of our series, 
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representing a non negligible 16% of the cases. In all these cases, PET/CT was determinant in 
establishing if infection was related to the prosthetic graft as shown in figure 3. Other authors have 
reported similar difficulties in interpreting these findings, and this is important since inaccurate diagnosis 
may lead to the administration of inadequate treatment with a substantial potential morbi-mortality 
derived from unneeded PVG extractions (8-9).The use of antibiotics prior to PET/CT negative results 
may be induced by scanning during or directly after antibiotic therapy if all signs and symptoms have 
abated, as is initially reported by Scholtens et al. in a recent case report (26).However, the mean duration 
of antibiotherapy in the two false negative patients was no significantly longer than in the remaining cases 
of PVGI. 
 
 This study has several limitations. Firstly, patients with PVGI represent a heterogeneous 
population with different causal microorganisms, different prosthetic materials and different localizations 
of infection. Secondly, most of the patients in this series underwent antibiotic therapy prior to PET/CT 
and this may have influenced 
18
F-FDG uptake and may be a cause of lower sensitivities, so prospective 
randomized larger series should be performed to analyze its effect. 
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NEW KNOWLEDGE GAINED 
 
 This is to our knowledge the first study with series of patients raising that PET/CT do not allow 
to distinguish between inflammation and infection in vascular grafts with surgical use of adhesives. 
Furthermore, our findings provide valuable guidelines regarding the interpretation of the different 
patterns of PET/CT uptake in the clinical management of PVGI. 
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CONCLUSIONS 
 
 PET/CT with 
18
F-FDG is recommended for the diagnosis of suspected PVGI which can be well 
characterized based on focal and diffuse uptake patterns to distinguish between inflammation and PVGI. 
The use of adhesives can mimic a heterogeneous patched uptake of 
18
F-FDG on PET/CT and 
consequently, these cases should be interpreted with caution as this pattern may also indicate the presence 
of inflammation. PET/CT can be recommended to ascertain PVG involvement versus soft tissue infection 
adjacent to the vascular graft, especially to exclude infected pseudoaneurysms or hematomas. 
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TABLES 
 
Table 1: Demographic characteristics of the study group. 
 
Characteristics 
 
All cases 
(n= 49) 
 
Confirmed PVGI 
(n= 16) 
 
PVGI ruled out 
(n= 33) 
 
P 
 
Mean age (years) 
 
62±14 
 
61±14 
 
63±13 
 
0.62 
 
Sex, n (%) 
  Female 
  Male 
 
 
7 (14%) 
42 (86%) 
 
 
2 (12%) 
14 (88%) 
 
 
5 (15%) 
28 (85%) 
 
 
0.45 
0.04 
     
Vascular prosthesis
 
 
Location 
  Ascending aorta 
  Axillofemoral 
  Aortobifemoral 
  Aortoiliac 
  Femoropopliteal 
  Others 
 
Material 
  Dacron 
  PTFE 
  TAVI 
 
Treatment option 
  Open surgery 
  Endovascular 
  Hybrid surgery 
 
BioGlue 
 
 
 
 
16 
4 
9 
7 
6 
7 
 
 
23 
22 
4 
 
 
39 
8 
2 
 
12 
 
 
 
2 
1 
3 
1 
5 
4 
 
 
6 
10 
- 
 
 
14 
2 
0 
 
4 
 
 
 
14 
3 
6 
6 
1 
3 
 
 
17 
12 
4 
 
 
25 
6 
2 
 
8 
 
 
 
0.004 
0.62 
0.51 
0.12 
0.22 
0.97 
 
 
0.007 
0.81 
0.125 
 
 
0.56 
0.10 
0.11 
 
0.39 
AngioCT 
 
 
Median time from vascular graft 
(IQR†), months 
 
24 
 
 
6 (2-22) 
 
8 
 
 
10.5 (4-31) 
 
16 
 
 
4 (1-20) 
 
0.15 
 
 
0.16 
 
Antibiotics prior to PET/CT 
Yes 
 
44 
 
15 
 
29 
 
0.52 
Duration (days)(mean, SD) 
 
14±5 
 
 
13±4 
 
 
16±7 
 
 
0.33 
 
 
†IQR: interquartile range. 
PVGI:Prosthetic vascular graft infection. 
 
Page 19 of 33
Footer Text
Journal of Nuclear Cardiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 20
Table 2: Clinical presentation, microbiological findings and outcome of the sixteen patients with 
confirmed diagnosis of PVGI. 
 
 
 
Clinical & laboratory data 
· Intermittent claudication 
· Traumatic vascular graft injury 
· C-reactive protein, mg/dL (mean, SD) 
· Erythrocyte sedimentation rate(mean, SD) 
· Leukocytes, *10
9
/L(mean, SD) 
 
Causal microorganisms 
· Staphylococcus aureus 
· CoNS 
· Polymicrobial 
· GNR 
· Enterococcus faecalis 
· Escherichia coli 
· Not identified 
 
Diagnosis criteria 
· Clinical/Surgical 
     Pus 
     Exposed graft 
     Fistula 
     Graft insertion in an infected site* 
     Localized clinical features of PVGI* 
     Fever ≥38ºC* 
· Radiological 
Peri-graft fluid (≥3 mo) or gas (≥7 mo) on CT 
     Increase in peri-graft gas on serial imaging 
     Other suspicious signs on CT* 
Radiolabelled leukocyte uptake* 
· Microbiological and laboratory 
     Organisms from explanted graft 
     Organisms from intra-operative specimen 
     Organisms from percutaneous peri-graft fluid 
     Blood culture(s) positive* 
     Elevated inflammatory markers* 
 
 
n (%) 
 
7 (44) 
2 (12.5) 
8.1±9.1 
42±37 
6.5.±3.2 
 
 
1(6.25) 
4 (25) 
4 (25) 
2 (12.5) 
2 (12.5) 
2 (12.5) 
1 (6.25) 
 
 
 
2 (12.5) 
2 (12.5) 
3 (18.75) 
4 (25) 
6 (38) 
8 (50) 
 
4 (25) 
- 
7 (44) 
1 (6.25) 
 
6 (38) 
4 (24) 
2 (12.5) 
8 (50) 
13 (81.25) 
 
Vascular surgery 
 
Timing 
· Early (<3 months) 
· Late (≥3 months) 
 
Mortality related to PVGI episode 
 
10 (62) 
 
 
3 (18.75) 
13 (81.25) 
 
3 (19) 
 
CoNS: coagulase-negative staphylococcus. 
GNR: Gram-negative rods. 
PVGI: Prosthetic vascular graft infection. 
*Minor criteria 
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FIGURE LEGENDS 
 
Figure 1: Example of a diffuse uptake pattern (arrowheads) with a dominant area of focal uptake 
(arrows) with a SUVmax of 6.7, shown in transverse and coronal PET (A) and fused PET/CT (B) images 
and considered as PVGI of the aortic bifemoral bypass. The vascular graft was removed and explant 
cultures were positive for coagulase-negative staphylococcus.  
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Figure 2: This is a case of suspected infection of a hybrid thoracic graft, consisting of open replacement 
of the ascending aorta and aortic arch, with bioglue, and endoprosthesis in the descending aorta. Fused 
PET/CT images show patched (arrows) 
18
F-FDG uptake (SUVmax= 8.3) predominantly at the proximal 
end of the vascular graft (A, B). 3D PET images and volume rendering fusion images clearly 
demonstrated intense uptake in the site where adhesives were deposited, indicating that the uptake was 
due to inflammatory changes (C). Patient follow up confirmed the integrity of the vascular graft.  
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Figure 3: Planimetry in the PET/CT coronal (A) and axial (B) axes shows a focal uptake suggestive of 
PVGI of a femoropopliteal by pass (arrows), which can be precisely located adjacent to the vascular graft 
after volume rendering image fusion (C) corresponding to an infected hematoma (SUVmax= 5.2). 
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Figure 4: AUC including the sensitivity and specificity of the SUVmax (A) and the M-TBR (B).The best 
performansce points for ROC curves are shown by arrows. 
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DIAGNOSTIC YIELD OF 18F-FDG PET/CT IN 
SUSPECTED DIAGNOSIS OF VASCULAR GRAFT 
INFECTION: A PROSPECTIVE COHORT STUDY 
Hans Bowles1*, Juan Ambrosioni2,6*, Gaspar Mestres3, Marta Hernández-Meneses2, Nuria Sánchez1, Jaime LLopis4, Xavier Yugueros3, Manel 
Almela5, Asuncion Moreno2,6, Vicenç Riambau3, David Fuster1,6, Jose M Miro2,6, Hospital Clinic Endocarditis Study Group†. 
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BACKGROUND 
1- Prosthetic vascular graft infection (PVGI) is a severe 
complication associated with high morbidity and mortality. 
 
2- Clinical diagnosis is complex, requiring image testing 
such as CT angiography or leukocyte scintigraphy, which 
have considerable limitations. 
 
3- The aim of this study was to know the diagnostic yield of 
PET/CT with 18F-Fluorodeoxyglucose (18F-FDG) in patients 
with suspected PVGI. 
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METHODS 
A. Study type: Prospective cohort study. 
 
B. Study subjects: 49 consecutive patients with suspected PVGI attended in 
an 850-bed university hospital from June 2014 to July 2016. 
 
C. Study endpoints: 
A. Primary end point(s): to evaluate the diagnostic yield of PET/CT in 
patients with suspected PVGI. 
B. Secondary end point(s): to determine the usefulness of PET/CT to 
discriminate between PVGI and infectious processes of adjacent 
tissues and the influence of bioglue in 18F-FDG uptake. 
 
D. Study variables: maximum standardized uptake value (SUVmax) and 18F-
FDG uptake uptake patterns.  
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RESULTS 
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• In our series, 18F-FDG PET/ CT was able to identify 14/16 cases of PVGI showing a focal (n=10) 
or patched pattern (n=4) and was true negative in 26/33 cases with either a diffuse pattern (n=16) 
or without uptake (n=10). The remaining 7/33 non infected cases were considered as false 
positive results and showed a patched (n=6) or focal (n=1) uptake. 
 
• The sensitivity, specificity, PPV and NPV for 18F-FDG PET/CT to diagnose PVGI were 88%, 79%, 
67% and 93%, respectively. 
 
• Five out of the 7 false positive cases (71%) showed a patched pattern (2 cases in the anastomotic 
site and 3 cases throughout the vascular graft), coinciding with the application of adhesives for 
PVG placement. When these cases were excluded from the analysis, these PET/CT values rose 
to up to 88%, 93%, 87% and 93%, respectively. 
 
• Additionally, PET/CT identified all the extra-prosthetic infections not identified by other procedures 
in the area surrounding the vascular graft: abscesses (n=2), aneurysm (n=3), infected hematoma 
(n=2) and sternal osteomyelitis (n=1). 
 
Page 32 of 33
Footer Text
Journal of Nuclear Cardiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
CONCLUSIONS 
1- PET/CT with 18F-FDG is recommended for the diagnosis of 
suspected PVGI which can be well characterized based on focal and 
diffuse uptake patterns to distinguish between inflammation and PVGI.  
 
2- The use of adhesives can mimic a heterogeneous patched uptake of 
18F-FDG on PET/CT and consequently, these cases should be 
interpreted with caution as this pattern may also indicate the presence 
of inflammation. 
 
3- PET/CT can be recommended to ascertain PVG involvement versus 
soft tissue infection adjacent to the vascular graft, especially to exclude 
infected pseudoaneurysms or hematomas. 
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